Àüü ÁÖ¿ä´º½º Á¶°£ºê¸®ÇÎ °æÁ¦ ±¹Á¦ Á¤Ã¥ ±ÝÀ¶ ä±Ç ÁÖ½Ä ¿Üȯ ±âŸ
   
ÀÏÀÚ Á¦¸ñ Ãâó ¼±ÅÃ
16:23 [ÁÖ½Ä]¡°ÃÖÀ±¹üÀº Ã¥ÀÓ°¨ ÀÖ´Â ¸®´õ¡±¡¦Ú¸»ó¿øÀÇ¿ø ¡®ÇÁ·ÎÁ§Æ® Å©·ç¼­.. ¸ÅÀϰæÁ¦
16:22 [ÁÖ½Ä]¾ÆÀÌÆ¼¼¾Å¬·ÎÀÕ, Å¥½ºÄÚ¿Í ¼ÕÀâ°í ´ç±¸ DX ½ÃÀå °ø·« ¸ÅÀϰæÁ¦
16:22 ³ë¸Ó½º, 10¾ï¿ø ±Ô¸ð ÀÚ»çÁÖ Ãëµæ ½Åʰè¾à ü°á À̵¥Àϸ®
16:21 ½ºÅæºê¸´Áöº¥Ã³½º, ¾Æ¸£°í½º¾ÆÀ̵§Æ¼Æ¼ ÇÁ¸®A ÅõÀÚ ¿Ï·á ¾Æ½Ã¾Æ°æÁ¦
16:18 LSÁõ±Ç, Çö´ëÂ÷Áõ±Ç°ú CERCG ABCP ¼Ò¼Û Á¾°á¡¦È­Çرǰí È®Á¤ À̵¥Àϸ®
16:17 [Neuraptive Therapeutics, Inc.]Neuraptive Therapeutics Licenses I.. ´º½º¿ÍÀ̾î
16:17 [Neuraptive Therapeutics, Inc.]´º¶óÇÁƼºê Å×¶óǻƽ½º, ¼¼ÀÎÆ®·çÀ̽º.. ´º½º¿ÍÀ̾î
16:16 ÄÚ½ºÇÇ, 6% ¿À¸¥ 7200 ÈÄ¹Ý ¸¶°¨¡¦ÄÚ½º´Úµµ 820¼± ȸº¹ ¾Æ½Ã¾Æ°æÁ¦
16:16 [ÁÖ½Ä]ASML, ¶Ç´Ù½Ã ¸ÅÃâ °¡ÀÌ´ø½º »óÇ⡦"¹ÝµµÃ¼ °íÁ¡ ¿ì·Á ºÒ½Ä" Çѱ¹°æÁ¦
16:11 ¡®50% ÇÁ¸®¹Ì¾ö¡¯ ºÙÀº SKÇÏÀ̴нº ADR¡¦º»ÁÖ ÁÖ°¡ °ßÀÎ? À̵¥Àϸ®
16:11 [ÁÖ½Ä]³²¾çÀ¯¾÷, ¾ÖÇÁÅ͸¶Äϼ­ 10%´ë ±Þµî ¿¬ÇÕ´º½º
16:09 [ÁÖ½Ä]´ëÅë·É ÇѸ¶µð¿¡ ÀÌÆ²Â° »ó½ÂÇÑ Çö´ë¾àǰ¡¦"Å»¸ð¾à µ¥ÀÚºß" ¿ì·Á.. Çѱ¹°æÁ¦
16:07 [ÁÖ½Ä]¡°º£Å×¶û ³ëÇÏ¿ì Ȱ¿ë¡±¡¦³²ºÎ¹ßÀü, ÀÓ±ÝÇÇÅ© Á÷¿ø°ú ¡®¾ÈÀüµ¿Çà.. ¸ÅÀϰæÁ¦
16:07 [SINOVAC Biotech Ltd.]SINOVAC Announces Extension of Deadline to .. ´º½º¿ÍÀ̾î
16:06 »ó¹Ý±â ÀÚ»çÁÖ Ãëµæ 20Á¶ À°¹Ú¡¦ÃÖ±Ù 5³â°£ ÃÖ´ëÄ¡ À̵¥Àϸ®
ÀÌÀü   ÀÌÈÄ